Riskpilot← Back to searchSign inGet full accessSynartro AB
ABActiveOrg 5568664220Dalgatan 16 AResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20113 employees
Revenue 2024
SEK 0
EBITDA margin
—
+31% vs 2023
Equity ratio
94.4%
Financial strength
Net profit 2024
SEK -5,6M
+25% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -5M | +31% |
| Net profit | SEK -5,6M | +25% |
| Total assets | SEK 50,2M | +26% |
| Equity | SEK 47,4M | +49% |
| Employees | 3 | — |
Legal name
Synartro AB
Org number
5568664220
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
4 oktober 2011
Share capital
SEK 640 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas av en av ledamöterna i förening med Hurst, Magnus Oliver Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall utveckla och kommersialisera läkemedel och bedriva därmed förenlig verksamhet.
Address
Dalgatan 16 A
Email
info@synartro.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 75 | −47 | −140 | −94 | −2 491 | −4 981 | −7 996 | −8 772 | −7 171 | −4 953 |
| Depreciation & amort. | −0 | −0 | −0 | −6 | −6 | −6 | −17 | −71 | −113 | −137 |
| EBIT | 75 | −47 | −140 | −100 | −2 497 | −4 987 | −8 013 | −8 843 | −7 284 | −5 090 |
| Net financials | — | — | −7 | −11 | −11 | −8 | −7 | −6 | −156 | −517 |
| Profit before tax | 74 | −47 | −147 | −109 | −2 507 | −4 994 | −8 020 | −8 849 | −7 480 | −5 635 |
| Tax | −16 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 58 | −47 | −147 | −109 | −2 507 | −4 994 | −8 020 | −8 849 | −7 480 | −5 635 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 136 | 69 | 309 | 297 | 1 993 | 17 556 | 44 419 | 36 352 | 39 920 | 50 191 |
| Equity | 100 | 53 | 86 | 87 | 159 | 16 328 | 40 318 | 31 468 | 31 822 | 47 387 |
| Long-term debt | 0 | 0 | 175 | 142 | 106 | 62 | 18 | 0 | 6 179 | 0 |
| Short-term debt | 36 | 16 | 48 | 68 | 1 729 | 1 167 | 4 083 | 4 884 | 1 919 | 2 805 |
| Total debt | 36 | 16 | 223 | 210 | 1 835 | 1 229 | 4 101 | 4 884 | 8 098 | 2 805 |
EBITDA margin
-495300000.0%
This company
15.8%
Market median
-3134810227% vs market
20152024
Equity ratio
94.4%
This company
38.2%
Market median
+147% vs market
20152024
Return on equity
-11.9%
This company
18.4%
Market median
-165% vs market
20152024
Net profit margin
-563500000.0%
This company
8.1%
Market median
-6956790223% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KM Auditor Substitute | Auditor Substitute | 2022 | — | — |
PG Audit | Audit | 2022 | — | — |
MB Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
ME Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
MO Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Synartro AB 
Synartro Ventures ABBoard members of Synartro AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karin Maria Francois | Auditor Substitute | 0 companies |
| Per Gustaf Hammar | Audit | 0 companies |
| Mia Barbro Maria Brundin | Chief Executive Officer | 0 companies |
| Monika Elisabet Vedin | Chief Executive Officer | 0 companies |
| Magnus Oliver Hurst | Chief Executive Officer | 0 companies |
| Corine Marie Sandström | Deputy Board Member | 0 companies |
| Hilda Maria Nyhage | Board of Directors | 0 companies |
| Rune Andreas Ringom | Board of Directors | 0 companies |
| Per Fredrik Lehmann | Chairman | 0 companies |
| Bengt Lennart Herman Lindqvist | Chairman | 0 companies |
| Mats Göte Uno Persson | Board of Directors | 0 companies |
| Arvid Tobias Thornblad | Board of Directors | 0 companies |
| Lena Margareta Torlegård | Board of Directors | 0 companies |
| Lars Håkan Wilhelm Jansson | Board of Directors | 0 companies |